Review of Operations Directors’ Report Chairman’s Letter CEO’s Report Financial Report Shareholder Information 5 OPERATING EXPENDITURES For the year ended 30 June 2025 $ For the year ended 30 June 2024 $ General and Administration Employee Expenditure - Staff wages and superannuation 1,551,887 1,404,370 - Directors’ fees 351,325 259,058 - Other employment expenses 987,021 1,009,055 2,890,233 2,672,483 Administrative Costs - Professional and legal fees 634,879 612,005 - ASX listing and transaction fees plus share registry fees 80,750 134,137 - Lease liability interest 21,734 40,766 - Other administration expenses 556,359 495,207 1,293,723 1,282,115 Depreciation and amortisation - Amortisation of acquired intangible asset - hTERT 54,783 54,933 - Amortisation of acquired intangible asset - Molecular Nets 890,142 892,581 - Amortisation of granted patents 35,070 28,385 - Depreciation of building improvements 24,168 24,168 - Depreciation of right-of-use assets – AASB 16 Leases 96,788 137,877 - Depreciation of plant and equipment 28,173 66,046 1,129,124 1,203,990 Per consolidated Statement of Comprehensive Income 5,313,080 5,158,586 43 Annual Report 2025
RkJQdWJsaXNoZXIy MjE2NDg3